发明名称 |
Treatment of renal disease |
摘要 |
The present invention provides compounds and methods for the treatment and prophylaxis of renal disease and inflammation. In particular the invention provides methods for the treatment of kidney disease and failure through the administration of compounds which function as inhibitors of TLR2 function and expression. |
申请公布号 |
US9234046(B2) |
申请公布日期 |
2016.01.12 |
申请号 |
US201213526873 |
申请日期 |
2012.06.19 |
申请人 |
OPSONA Therapeutics Ltd |
发明人 |
Heffernan Mark;O'Neill Luke;McGuirk Peter;Keogh Brian;Locher Christopher |
分类号 |
A61K39/395;C07K16/28;C07K14/705;A61K45/06;A61P13/12;C12N5/07;A61K38/00;A61K39/00 |
主分类号 |
A61K39/395 |
代理机构 |
Wolf, Greenfield & Sacks, P.C. |
代理人 |
Wolf, Greenfield & Sacks, P.C. |
主权项 |
1. A method for the treatment of a renal disorder, the method comprising administering a therapeutically effective amount of an antibody or an antigen binding fragment thereof, which has binding specificity for Toll-like Receptor 2 and which is an antagonist of the function of Toll-like Receptor 2, to a subject in need of such treatment, wherein said subject has not been administered said antibody or antigen binding fragment thereof prior to the onset of the renal disorder. |
地址 |
Dublin IE |